Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Sunday, July 15, 2012 - 11:30am
tags:
Xoma, Jazz Pharmaceuticals, Pacific Biosciences, Amylin, Corcept Therapeutics, Santarus, Affymetrix, Ariad Pharmaceuticals, Amyris, Sequenom
3 Reasons to Buy Spectrum Pharmaceuticals
Motley Fool
Sunday, July 15, 2012 - 11:28am
tags:
Spectrum Pharmaceuticals
Why Incyte Could Be Headed Even Higher
Motley Fool
Sunday, July 15, 2012 - 11:27am
tags:
Incyte
Will the FDA Approve VIVUS' Obesity Drug?
Motley Fool
Sunday, July 15, 2012 - 11:25am
tags:
Vivus, obesity, weight loss, Qnexa
Buy Yourself Something Pretty
Motley Fool
Sunday, July 15, 2012 - 11:24am
tags:
Obagi Medical Products
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sunday, July 15, 2012 - 11:22am
tags:
Alkermes, Medivation, Cubist Pharmaceuticals, Ariad Pharmaceuticals, Questcor Pharmaceuticals, Arena Pharmaceuticals, Seattle Genetics, Incyte, United Therapeutics, Amarin, ONYX Pharmaceuticals, Pharmacyclics, Human Genome Sciences, Theravance
Ryan & Maniskas, LLP Files Class Action Lawsuit Against PolyMedix, Inc.
Yahoo/BusinessWire
Sunday, July 15, 2012 - 11:18am
tags:
PolyMedix
China may not produce for Big Pharma long-term
Fierce Pharma
Friday, July 13, 2012 - 2:48pm
tags:
China, Big Pharma
Questcor Falls After Failing To Quell Citron Concerns
Investors.com
Friday, July 13, 2012 - 2:47pm
tags:
Questcor, Acthar
Seattle Genetics CEO Says Drug Growth Path Means No Sale
Bloomberg
Friday, July 13, 2012 - 1:29pm
tags:
Seattle Genetics, M&A, Pharma CEOs, Clay Siegall
Questcor's Acthar Is One Hot Drug
Seeking Alpha
Friday, July 13, 2012 - 1:28pm
tags:
Acthar, Questcor, MS, multiple sclerosis
Icahn issues new warning to board of Forest Labs
Yahoo/Reuters
Friday, July 13, 2012 - 1:26pm
tags:
Forest Labs, Carl Icahn
Watson Pharmaceuticals subsidiary receives approval from FDA for ONE DOSE
The Fly on the Wall
Friday, July 13, 2012 - 1:25pm
tags:
Watson Pharmaceuticals, FDA, One Dose, One-Step, Teva Pharmaceuticals
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Friday, July 13, 2012 - 1:23pm
tags:
GSK, Amylin, AstraZeneca, Merck, Novartis, Pfizer
The Challenges in Staying #1 in Big Pharma
Forbes
Friday, July 13, 2012 - 1:22pm
tags:
Merck, Novartis, Pfizer, AstraZeneca
Alzheimer's Drug Research at Make or Break Juncture
Forbes
Friday, July 13, 2012 - 12:45pm
tags:
Alzheimer's disease, Merck, Pfizer, Eli Lilly, JNJ
Keryx: A Lot Can Go Wrong At $2
Seeking Alpha
Friday, July 13, 2012 - 12:44pm
tags:
Keryx, Valeant Pharmaceuticals, Pfizer, Arena Pharmaceuticals, Allos, Abbott Laboratories
GlaxoSmithKline rises on US and Europe drug submission, amid renewed talk of interest in Biomarin
Guardian, UK
Friday, July 13, 2012 - 12:30pm
tags:
GSK, Biomarin, M&A
Acadia drops schizophrenia drug after trial failure
Reuters
Friday, July 13, 2012 - 12:27pm
tags:
Acadia, schizophrenia, AM-831
Affymax Rises On Deal With Fresenius For Kidney Therapy
Bloomberg
Friday, July 13, 2012 - 12:25pm
tags:
Affymax, Fresenius, Omontys, anemia, Takeda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.